Pioneers
We use our knowledge in HPV diagnostics realising an optimal cancer patient management
Abviris addresses the globally increasing problem of cancer caused by the human papillomavirus (HPV). We are dedicated to improving the clinical outcomes of patients and enable clinicians worldwide to fight HPV-induced tumours, including head and neck cancer, penile and anal tumours, vaginal and vulvar cancer and of course cervical cancer. Our patented diagnostics support factors that are key to a favourable prognosis, such as early tumour detection and post-therapy patient management. As pioneers in HPV serology, we develop highly innovative solutions, including Prevo-Check®, the world“s first entire-body screening test for HPV16-induced cancer, which can be performed with a single drop of blood within minutes.
About

2020
2019
2018
2016
2015
2014